Global Pharmaceuticals Brands

A blister pack containing Lamictal anti-epileptic tablets, produced by GlaxoSmithKline Plc, sits on a pharmacy counter in this arranged photograph in London, U.K., on Thursday, Dec. 29, 2016. The rapid pace of innovation among drugmakers may continue to be overshadowed by broader investment themes, such as the switch away from defensive stocks into more cyclical industries, during 2017, according to Bloomberg Intelligence. Photographer: Chris Ratcliffe/Bloomberg via Getty Images
A blister pack containing Lamictal anti-epileptic tablets, produced by GlaxoSmithKline Plc, sits on a pharmacy counter in this arranged photograph in London, U.K., on Thursday, Dec. 29, 2016. The rapid pace of innovation among drugmakers may continue to be overshadowed by broader investment themes, such as the switch away from defensive stocks into more cyclical industries, during 2017, according to Bloomberg Intelligence. Photographer: Chris Ratcliffe/Bloomberg via Getty Images
Global Pharmaceuticals Brands
COMPRAR LICENCIA
¿Cómo puedo usar esta imagen?
475,00 €
EUR

DETALLES

Restricciones:
Póngase en contacto con su oficina local para conocer todos los usos con fines comerciales o promocionales.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédito:
Bloomberg / Colaborador
Editorial n.º:
630649574
Colección:
Bloomberg
Fecha de creación:
29 de diciembre de 2016
Fecha de subida:
Tipo de licencia:
Con derechos gestionados
Inf. de autorización:
No se cuenta con autorizaciones. Más información
Fuente:
Bloomberg
Nombre del objeto:
UK PHARMA
Tamaño máx. archivo:
4000 x 2622 px (33,87 x 22,20 cm) - 300 dpi - 5 MB